{"id":56406,"date":"2023-05-01T22:04:43","date_gmt":"2023-05-01T20:04:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/"},"modified":"2023-05-01T22:04:43","modified_gmt":"2023-05-01T20:04:43","slug":"mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/","title":{"rendered":"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–$MNMD<\/a>–Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the \u201cCompany\u201d or “MindMed\u201d), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Thursday, May 4, 2023, at 4:30 p.m. ET to provide a corporate update and review the Company\u2019s results for the quarter ended March 31, 2023.<\/p>\n

<\/a><\/p>\n

\nIndividuals may participate in the live call via telephone by dialing (888) 396-8049 (domestic) or (416) 764-8646 (international). The webcast can be accessed live here<\/a> on the Financials page in the Investors section of the MindMed website, https:\/\/mindmed.co\/.<\/a> The webcast will be archived on the Company\u2019s website for at least 30 days after the conference call.<\/p>\n

\nAbout MindMed<\/b><\/p>\n

\nMindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.<\/p>\n

\nMindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.<\/p>\n

Contacts<\/b> <\/p>\n

\nFor Media & Investor Inquiries:<\/p>\n

\nMaxim Jacobs, CFA
\n
Vice President, Investor Relations and Corporate Communications
\n
Mind Medicine (MindMed) Inc.
\n
ir@mindmed.co<\/a>
media@mindmed.co<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–$MNMD–Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the \u201cCompany\u201d or “MindMed\u201d), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Thursday, May 4, 2023, at 4:30 p.m. ET to provide a corporate update and review the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56406","6":"format-standard","7":"category-industry"},"yoast_head":"\nMindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–$MNMD–Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the \u201cCompany\u201d or “MindMed\u201d), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Thursday, May 4, 2023, at 4:30 p.m. ET to provide a corporate update and review the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T20:04:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230501005575\/en\/1767510\/21\/logoStacked_multi.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update\",\"datePublished\":\"2023-05-01T20:04:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/\"},\"wordCount\":248,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005575\\\/en\\\/1767510\\\/21\\\/logoStacked_multi.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/\",\"name\":\"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005575\\\/en\\\/1767510\\\/21\\\/logoStacked_multi.jpg\",\"datePublished\":\"2023-05-01T20:04:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005575\\\/en\\\/1767510\\\/21\\\/logoStacked_multi.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005575\\\/en\\\/1767510\\\/21\\\/logoStacked_multi.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/","og_locale":"en_US","og_type":"article","og_title":"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–$MNMD–Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the \u201cCompany\u201d or “MindMed\u201d), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Thursday, May 4, 2023, at 4:30 p.m. ET to provide a corporate update and review the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-01T20:04:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230501005575\/en\/1767510\/21\/logoStacked_multi.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update","datePublished":"2023-05-01T20:04:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/"},"wordCount":248,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230501005575\/en\/1767510\/21\/logoStacked_multi.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/","url":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/","name":"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230501005575\/en\/1767510\/21\/logoStacked_multi.jpg","datePublished":"2023-05-01T20:04:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230501005575\/en\/1767510\/21\/logoStacked_multi.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230501005575\/en\/1767510\/21\/logoStacked_multi.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-host-conference-call-and-webcast-to-discuss-first-quarter-2023-financial-results-and-provide-business-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56406"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56406\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}